Researching: Novo Nordisk

CHMP Diverges from FDA, Backs AZ’s Camizestrant and Novo’s Oral Wegovy

Supreme Court shuts door on pharma's Inflation Reduction Act appeals

Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies

Novo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech

Novo Nordisk’s Wegovy pill lifts Q1 and investor confidence

Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's

STAT+: FDA wants to exclude weight loss drugs from a compounding list

OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Novo Nordisk Bets on OpenAI to Accelerate Drug Development

Lilly’s Foundayo Scores a Cardiovascular Win, Easing FDA Concerns Ahead of Diabetes Filing